A literature review on off-label drug use in children
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Unlabelled The aim was to compare results of studies performed in different settings worldwide and identify common therapeutic areas to allow for focused interventions, because off-label drug use can be a measure of the lack of knowledge concerning paediatric treatments. A secondary objective was to provide a brief review of efforts to date. A literature review of articles on off-label and unlicensed drug use in children involving general prescription samples was performed using Medline and Embase. In all, 30 studies from 1985-2004 were included. Eleven involved paediatric hospital wards, seven neonatal hospital wards, and 12 the community setting. The off-label and unlicensed classification methods varied, making results difficult to compare. In general, off-label/unlicensed prescription rates ranged from 11%-80%, and higher rates were found in younger versus older patients and in the hospital versus community settings. On the paediatric hospital wards, off-label/unlicensed prescriptions ranged from 16%-62% and most often concerned acetaminophen, cisapride, chloral hydrate, and salbutamol. In the neonatal wards, rates ranged from 55%-80% and often involved caffeine. In the community setting, rates ranged from 11%-37% and the most commonly implicated drugs were salbutamol and amoxicillin.Conclusion A lack of harmonization between the evidence, the information available to doctors, and its use in clinical practice exists and this is part of the reason off-label therapies are so common. Attempts have been made to improve knowledge concerning paediatric treatments, but more focused interventions are needed, also taking into consideration this lack of harmonization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In most countries, paracetamol is the most used analgesic-antipyretic drug in children (21,158,179).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [158]
Citations
Cites
Survey of unlicensed and off label drug use in paediatric wards in European countries
Conroy, S. (2000) · BMJ · doi:10.1136/bmj.320.7227.79 · Cited by 735
Caldwell, P. H., Murphy, S. B., Butow, P. N., & Craig, J. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16942-0 · Cited by 490
Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study
Turner, S., Nunn, A., Fielding, K., & Choonara, I. (1999) · Acta Paediatrica · doi:10.1080/08035259950168469 · Cited by 411
Unlicensed and off label drug use in paediatric wards: prospective study
Turner, S., Longworth, A., Nunn, A. J., & Choonara, I. (1998) · BMJ · doi:10.1136/bmj.316.7128.343 · Cited by 317
Adverse drug reactions to unlicensed and off‐label drugs on paediatric wards: a prospective study
Turner, S. J., Nunn, A., Fielding, K., et al. (1999) · Acta Paediatrica · doi:10.1111/j.1651-2227.1999.tb00191.x · Cited by 314
Pediatric Drug Labeling: Improving the Safety and Efficacy of Pediatric Therapies
Roberts, R., Rodriguez, W., Murphy, D., & Crescenzi, T. (2003) · JAMA · doi:10.1001/jama.290.7.905 · Cited by 299
Adverse drug reactions and off-label drug use in paediatric outpatients
Horen, B., Montastruc, J.-L., & Lapeyre-Mestre, M. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.t01-3-01689.x · Cited by 294
Unlicensed and off label drug use in neonates
Conroy, S., McIntyre, J., & Choonara, I. (1999) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.80.2.f142 · Cited by 286
Unlicensed and off label prescribing of drugs in general practice
McIntyre, J. (2000) · Archives of Disease in Childhood · doi:10.1136/adc.83.6.498 · Cited by 234
Unlicensed and Off-Label Drug Use in Children: Implications for Safety
Choonara, I., & Conroy, S. (2002) · Drug Safety · doi:10.2165/00002018-200225010-00001 · Cited by 224
Research works printed but not linked: 6
- Avenel S, Bomkratz A, Dassieu G, Janaud JC, Danan C (2000) The incidence of prescriptions without marketing product license in a neonatal intensive care unit. Arch Pediatr: 143–147
- Department of Health and Human Services, United States Food and Drug Administration (1994) Specific requirements on content and format of labeling for human prescription drugs; revision of the “pediatric use’ subsection in the labeling. Federal Register 59: 64240
- Kleist P (2002) Authorities recognize a need to encourage pediatric drug development. Applied Clinical Trials 11: 408
- Pandolfini C, Bonati M, Giozani M, Raffaelli MP, Rossi R, Serra G, Joppi R, Temporin G (2003) Off-label and unlicensed drug use in neonatal wards of three different Italian hospitals (abstract). Paed Perinat Drug Ther 5: 169
- Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients (1998) Federal Register 63: 66632
- Wilton LV, Pearce G, Mann RD (1999) The use of newly marketed drugs in children and adolescents prescribed in general practice. Pharmacoepidemiol Drug Safety 8: S37–S45 · doi:10.1002/(sici)1099-1557(199904)8:1+<s37::aid-pds400>3.3.co;2-0
Cited by
Paracetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 674
“In most countries, paracetamol is the most used analgesic-antipyretic drug in children (21,158, 179).”
BackgroundBeasley, R., Clayton, T., Crane, J., von Mutius, E., Lai, C. K., Montefort, S., & Stewart, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61445-2 · Cited by 436
Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity
Ghanem, C. I., Pérez, M. J., Manautou, J. E., & Mottino, A. D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.020 · Cited by 384
Pediatric Drug Formulations: A Review of Challenges and Progress
Ivanovska, V., Rademaker, C. M. A., van Dijk, L., & Mantel-Teeuwisse, A. K. (2014) · Pediatrics · doi:10.1542/peds.2013-3225 · Cited by 324
Medication Use in the Neonatal Intensive Care Unit
Hsieh, E., Hornik, C., Clark, R., Laughon, M., Benjamin, D., Smith, P., & on Behalf of the Best Pharmaceuticals for Children Act—Pediatric Trials Network (2013) · American Journal of Perinatology · doi:10.1055/s-0033-1361933 · Cited by 318
Metadata
- Authors
- Pandolfini, C., & Bonati, M.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Corresponding author
- Pandolfini, Chiara
- Venue
- European Journal of Pediatrics
- Published
- 2005-05-24
- Volume
- 164
- Issue
- 9
- Pages
- 552-558
- ISSN
- 0340-6199 (ISSN-L)
- 1432-1076
- OpenAlex
- W1995444135
- Cited by
- 346
- References
- 74
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 8 · 2022: 16 · 2021: 18 · 2020: 14 · 2019: 22 · 2018: 19 · 2017: 15 · 2016: 20 · 2015: 32 · 2014: 25 · 2013: 20 · 2012: 31
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Journal of Pediatrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- off-label drug use, unlicensed drug use, pediatric prescribing, children, neonates, hospital wards, community prescribing, paracetamol, cisapride, chloral hydrate, salbutamol, caffeine, amoxicillin, knowledge-practice gap, therapeutic areas
- MeSH terms
- Adolescent, Adult, Age Factors, Child, Child, Preschool, Community Health Services, Drug Labeling, Hospitals, Pediatric, Humans, Infant, Infant, Newborn, Legislation, Drug, Drug Prescriptions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A literature review on off-label drug use in children. https://app.cochat.ai/papers/10.1007/s00431-005-1698-8
- The paper
- Pandolfini, C., & Bonati, M. (2005). A literature review on off-label drug use in children. European Journal of Pediatrics. https://doi.org/10.1007/s00431-005-1698-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.